Gibraltar Business Capital (GBC) has increased its asset-based line of credit for Prodigy Health, a specialty pharmaceutical distributor.
GBC provided an initial $25 million line of credit that allowed Prodigy to expand its distribution capabilities. In 2024, as Prodigy’s business model shifted to focus on higher-turn products and new customer segments, GBC responded by expanding the facility to $30 million.
Now, with Prodigy’s continued growth and changing market dynamics, GBC has approved another line of credit increase to $35 million.
